← Back to Search

Brain Stimulation

Transcranial Magnetic Stimulation for Chronic Pain

N/A
Waitlist Available
Led By Mar Cortes, M.D.
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial is investigating whether transcranial magnetic stimulation (TMS) is an effective treatment for chronic neuropathic pain (CNP) in people with spinal cord injury (SCI). TMS is a non-invasive brain stimulation technique that is painless and has shown promising effects in neuropathic pain in other studies. This study will compare the effects of real TMS versus a sham (fake) TMS treatment. Clinical, functional, and neurophysiological evaluations will be done before and after the treatment, and also at a 6-week follow-up.

Eligible Conditions
  • Chronic Pain
  • Spinal Cord Injury
  • Neuralgia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neuropathic Pain Scale (NPS)
Secondary outcome measures
Beck Depression Inventory (BDI)
Modified Ashworth Scale (MAS)
Numeric Rating Scale (NRS)
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Real rTMS groupExperimental Treatment1 Intervention
Repetitive TMS at 20Hz frequency over the M1 will be performed for five consecutive days for 2 weeks (using 90% of the resting motor threshold/total of 500 pulses). The rTMS will be applied through a figure-8 coil connected to a magnetic stimulator, which provides a biphasic pulse. This protocol was developed in accordance with the guidelines for the safe use of rTMS.
Group II: Sham groupPlacebo Group1 Intervention
Sham stimulation will be performed for five consecutive days for 2 weeks (using 90% of the resting motor threshold/total of 500 pulses). For the sham stimulation a sham coil will be used.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
857 Previous Clinical Trials
524,271 Total Patients Enrolled
6 Trials studying Chronic Pain
639 Patients Enrolled for Chronic Pain
Mar Cortes, M.D.Principal InvestigatorIcahn School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current patient enrollment for this clinical trial?

"Affirmative. Per the information hosted on clinicaltrials.gov, this research endeavour is presently enrolling participants and posted for the first time on September 1st 2022. Approximately 30 patients will be required from a single medical site."

Answered by AI

Are there any opportunities to join the current clinical trial?

"According to the details provided on clinicaltrials.gov, this clinical trial is currently accepting participants. It was first made available on September 1st 2022 and has undergone its most recent update on July 20th 2022."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
65+
What site did they apply to?
Abilities Research Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Abilities Research Center: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI
Maria Del Mar Cortes 2023. "Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05226676.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top